HORMONAL-THERAPY OF PROSTATIC-CANCER

被引:160
作者
SCOTT, WW [1 ]
MENON, M [1 ]
WALSH, PC [1 ]
机构
[1] JOHNS HOPKINS MED INST, BRADY UROL INST, BALTIMORE, MD 21205 USA
关键词
D O I
10.1002/cncr.1980.45.s7.1929
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1929 / 1936
页数:8
相关论文
共 61 条
[1]   SELECTIVE RETENTION OF DIHYDROTESTO-STERONE BY PROSTATIC NUCLEI [J].
ANDERSON, KM ;
LIAO, S .
NATURE, 1968, 219 (5151) :277-&
[2]  
BAKER H W G, 1973, Clinical Endocrinology, V2, P297, DOI 10.1111/j.1365-2265.1973.tb01715.x
[3]  
BAYARD S, 1974, CANCER CHEMOTH REP 1, V58, P845
[4]  
Blackard C E, 1973, Urology, V1, P553, DOI 10.1016/0090-4295(73)90515-3
[5]   CORRELATION OF PRETREATMENT SERUM NONPROTEIN-BOUND CORTISOL AND TOTAL 17-HYDROXYCORTICOSTEROID VALUES WITH SURVIVAL IN PATIENTS WITH PROSTATIC CANCER [J].
BLACKARD, CE ;
BYAR, DP ;
SEAL, US ;
DOE, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (15) :751-755
[6]  
BLACKARD CE, 1975, CANCER CHEMOTH REP 1, V59, P225
[7]  
BRENDLER H, 1962, CANCER CHEMOTH REP, P323
[9]  
BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012
[10]   EXPONENTIAL MODEL RELATING CENSORED SURVIVAL DATA AND CONCOMITANT INFORMATION FOR PROSTATIC CANCER-PATIENTS [J].
BYAR, DP ;
HUSE, R ;
BAILAR, JC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (02) :321-326